Search Result "thalidomide tragedy"
Thalidomide: A Banned Drug Resurged into Future Anticancer Drug
Journal: Current Drug Therapy
Volume: 7 Issue: 1 Year: 2012 Page: 13-23
Author(s): Imran Ali,Waseem A. Wani,Kishwar Saleem,Ashanul Haque
Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 3 Year: 2005 Page: 395-401
Author(s): Kozo Yasui, Norimoto Kobayashi, Takashi Yamazaki, Kazunaga Agematsu
Thalidomide and Analogs as Anti-Inflammatory and Immunomodulator Drug Candidates
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 5 Issue: 1 Year: 2006 Page: 79-95
Author(s): Lidia M. Lima, Carlos A. Manssour Fraga, Vera L. Goncalves Koatz, Eliezer J. Barreiro
Thalidomide Derived Immunomodulatory Drugs (IMiDs) as Potential Therapeutic Agents
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3 Issue: 3 Year: 2003 Page: 181-186
Author(s): J Blake Marriott, Keith Dredge, Angus G. Dalgleish
Thalidomide in Multiple Myeloma
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 6 Year: 2006 Page: 431-440
Author(s): T. M. Moehler, J. Hillengass, A. Glasmacher, H. Goldschmidt
Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?
Journal: Current Molecular Pharmacology
Volume: 4 Issue: 1 Year: 2011 Page: 26-61
Author(s): Jurgen Knobloch, David Jungck, Andrea Koch
Clinical Experience with Thalidomide and Lenalidomide in Multiple Myeloma
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 372-390
Author(s): T. Moehler
To Evaluate the Acceptance/Rejection Rate of General Informed Consent in OPD Patients
Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 4 Issue: 2 Year: 2017 Page: 133-139
Author(s): Supreet Kaur Gill,Malika Arora,Vikas Gupta,Sanjay Gupta,Parveen Bansal
History and Evolution of Reproductive and Developmental Toxicology Guidelines
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1449-1465
Author(s): Thomas F.X. Collins